91 related articles for article (PubMed ID: 310906)
21. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Goldenberg GJ; Wang H; Blair GW
Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E
Cancer Res; 1991 Jan; 51(2):536-41. PubMed ID: 1985771
[TBL] [Abstract][Full Text] [Related]
23. [Colony-forming ability of bone marrow hematopoietic cells in mice with transplanted leukemia during administration of carminomycin].
Kozinets GI; Ivanova LE; Khanykova OK; Kuznetsova TV; Rudneva NA
Eksp Onkol; 1984; 6(5):59-62. PubMed ID: 6510345
[TBL] [Abstract][Full Text] [Related]
24. Comparative effects of G-CSF, GM-CSF and IL-3 on cytosine arabinoside- and daunorubicin-mediated cytotoxicity of acute myeloid leukemia cells and normal myeloid progenitors.
Waga K; Furusawa S; Nagashima S; Saito K; Shishido H
Int J Hematol; 1992 Aug; 56(1):17-27. PubMed ID: 1391803
[TBL] [Abstract][Full Text] [Related]
25. In vitro sensitivity to steroid hormones and cytotoxic agents of normal and malignant lymphocyte colony-forming cells.
Taetle R; To D; Mendelsohn J
Cancer Res; 1983 Aug; 43(8):3553-8. PubMed ID: 6602652
[TBL] [Abstract][Full Text] [Related]
26. Use of liquid culture and cell cycle analysis to compare drug damage following in vitro treatment of normal human bone marrow cells with adriamycin, arabinosyl-cytosine, and etoposide.
Cavazzana M; Calvo F; Facchin P; Barreau P; Geny B; Dal Cortivo L; Dresch C
Exp Hematol; 1988 Nov; 16(10):876-83. PubMed ID: 3169155
[TBL] [Abstract][Full Text] [Related]
27. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
Grant S; Bhalla K; Arlin Z; Howe CW
Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
[TBL] [Abstract][Full Text] [Related]
28. Normal and leukemic hemopoiesis compared.
McCulloch EA; Buick RN; Till JE
Cancer; 1978 Aug; 42(2 Suppl):845-53. PubMed ID: 278636
[TBL] [Abstract][Full Text] [Related]
29. Kinetics of cytotoxicity of VM-26 and VP-16-213 on L1210 leukemia and hematopoietic stem cells.
Vietti TJ; Valeriote FA; Kalish R; Coulter D
Cancer Treat Rep; 1978 Sep; 62(9):1313-20. PubMed ID: 688275
[TBL] [Abstract][Full Text] [Related]
30. Decreased retention of actinomycin D as the basis for cross-resistance in anthracycline-resistant sublines of P388 leukemia.
Inaba M; Johnson RK
Cancer Res; 1977 Dec; 37(12):4629-34. PubMed ID: 922743
[TBL] [Abstract][Full Text] [Related]
31. The effect of lithium chloride on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic leukaemic blasts (CFU-L) in the cultures in vitro.
Korycka A; Robak T
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):495-500. PubMed ID: 1668709
[TBL] [Abstract][Full Text] [Related]
32. In vitro myelotoxicity of 2',3'-dideoxynucleosides on human hematopoietic progenitor cells.
Du DL; Volpe DA; Grieshaber CK; Murphy MJ
Exp Hematol; 1990 Aug; 18(7):832-6. PubMed ID: 2379548
[TBL] [Abstract][Full Text] [Related]
33. Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cells.
Lagneaux L; Marie JP; Delforge A; Socquet M; Thevenin D; Zittoun R; Stryckmans P
Exp Hematol; 1989 Aug; 17(7):843-6. PubMed ID: 2753092
[TBL] [Abstract][Full Text] [Related]
34. Long-term marrow culture of cells from patients with acute myelogenous leukemia. Selection in favor of normal phenotypes in some but not all cases.
Coulombel L; Eaves C; Kalousek D; Gupta C; Eaves A
J Clin Invest; 1985 Mar; 75(3):961-9. PubMed ID: 3856572
[TBL] [Abstract][Full Text] [Related]
35. Self-renewal capacity of leukemic blast progenitor cells.
Buick RN; Chang LJ; Messner HA; Curtis JE; McCulloch EA
Cancer Res; 1981 Nov; 41(11 Pt 2):4849-52. PubMed ID: 6945908
[TBL] [Abstract][Full Text] [Related]
36. Activity of doxorubicin linked to poly-L-aspartic acid on normal murine hematopoietic progenitor cells.
Bogliolo G; Muzzulini C; Lerza R; Pannacciulli I
Cancer Treat Rep; 1986 Nov; 70(11):1275-81. PubMed ID: 3768872
[TBL] [Abstract][Full Text] [Related]
37. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
Carlo-Stella C; Tabilio A; Regazzi E; Garau D; La Tagliata R; Trasarti S; Andrizzi C; Vignetti M; Meloni G
Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879
[TBL] [Abstract][Full Text] [Related]
38. [An in vitro chemotherapy sensitivity test on leukemic colony-forming cells (L-CFU) and its clinical evaluation].
Moriyama Y; Urushiyama M; Hirosawa H; Koyama S; Takai K; Fujiwara M; Kishi K; Takahashi M; Sakai C; Sanada M; Shibata A
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1749-54. PubMed ID: 7184371
[TBL] [Abstract][Full Text] [Related]
39. Interferon protects normal human granulocyte/macrophage colony-forming cells from Ara-C cytotoxicity.
Richman CM; Slapak CA; Toh B
J Biol Response Mod; 1990 Dec; 9(6):570-5. PubMed ID: 1705960
[TBL] [Abstract][Full Text] [Related]
40. Survival of hematopoietic and leukemic colony-forming cells in vivo following the administration of daunorubicin or adriamycin.
Razek A; Valeriote F; Vietti T
Cancer Res; 1972 Jul; 32(7):1496-500. PubMed ID: 5030578
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
